申请人:Bhalay Gurdip
公开号:US20120071479A1
公开(公告)日:2012-03-22
Compounds of Formula I:
and pharmaceutically acceptable salts and solvates thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, and R
10
have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公式I的化合物:及其药用可接受的盐和溶剂化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10的含义如规范中所示,可用于治疗通过阻断上皮钠通道介导的疾病。还描述了含有这些化合物的药物组合物和制备这些化合物的过程。